CMA are pleased to inform members of the registration of the Therapeutic Goods (Standard for Tablets, Capsules and Pills) Amendment Order 2020, which provides a three-month extension to the requirements for elemental impurities and residual solvents in Section 16 of the TGO 101, from 31 March 2021 to the new commencement date of 30 June 2021.

More details on the above, as well as contextual information for sponsors on capsule and tablet size (due to member enquiries), can be found in today's technical alert.